355 related articles for article (PubMed ID: 27395420)
1. In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D
Wang H; Wang J; Qu H; Wei H; Ji B; Yang Z; Wu J; He Q; Luo Y; Liu D; Duan Y; Liu F; Deng H
Endocrine; 2016 Nov; 54(2):348-359. PubMed ID: 27395420
[TBL] [Abstract][Full Text] [Related]
2. 1, 25(OH)2D3 protects β cell against high glucose-induced apoptosis through mTOR suppressing.
Yang Z; Liu F; Qu H; Wang H; Xiao X; Deng H
Mol Cell Endocrinol; 2015 Oct; 414():111-9. PubMed ID: 26213322
[TBL] [Abstract][Full Text] [Related]
3. 1α,25-Dihydroxyvitamin D
Wang D; Li Y; Wang N; Luo G; Wang J; Luo C; Yu W; Hao L
Am J Physiol Endocrinol Metab; 2020 Mar; 318(3):E343-E356. PubMed ID: 31891537
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D
Chen DP; Ma YP; Zhuo L; Zhang Z; Zou GM; Yang Y; Gao HM; Li WG
Oncotarget; 2018 Jan; 9(1):418-427. PubMed ID: 29416624
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the β-catenin/TCF4/GSK-3β/mTOR pathway.
Wei H; Qu H; Wang H; Ji B; Ding Y; Liu D; Duan Y; Liang H; Peng C; Xiao X; Deng H
J Steroid Biochem Mol Biol; 2017 Apr; 168():71-90. PubMed ID: 28216152
[TBL] [Abstract][Full Text] [Related]
6. 1,25(OH)
Qu H; Lin K; Wang H; Wei H; Ji B; Yang Z; Peng C; Xiao X; Deng H
Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27561793
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide protects from renal damage via Akt-mTOR pathway in rats with diabetic kidney disease.
Liao TT; Zhao LB; Liu H; He RL; Wang YQ; Li J
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):117-125. PubMed ID: 31389583
[TBL] [Abstract][Full Text] [Related]
8. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
[TBL] [Abstract][Full Text] [Related]
9. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
10. [1, 25(OH)
Liu G; Ren G; Yang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Mar; 38(3):224-230. PubMed ID: 35365987
[TBL] [Abstract][Full Text] [Related]
11. Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling.
Lisse TS; Liu T; Irmler M; Beckers J; Chen H; Adams JS; Hewison M
FASEB J; 2011 Mar; 25(3):937-47. PubMed ID: 21123297
[TBL] [Abstract][Full Text] [Related]
12. 1α,25-Dihydroxyvitamin D3 upregulates HIF-1 and TREM-1 via mTOR signaling.
Lee B; Kwon E; Kim Y; Kim JH; Son SW; Lee JK; Kim DW; Sohn J; Kim TH; Ji JD
Immunol Lett; 2015 Jan; 163(1):14-21. PubMed ID: 25448705
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
[TBL] [Abstract][Full Text] [Related]
14. DNA damage-inducible transcript 4 is an innate guardian for human squamous cell carcinoma and an molecular vector for anti-carcinoma effect of 1,25(OH)
Zhang X; Luo F; Li J; Wan J; Zhang L; Li H; Chen A; Chen J; Cai T; He X; Lisse TS; Zhao H
Exp Dermatol; 2019 Jan; 28(1):45-52. PubMed ID: 30372793
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion.
Lee S; Clark SA; Gill RK; Christakos S
Endocrinology; 1994 Apr; 134(4):1602-10. PubMed ID: 8137721
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
19. 1,25(OH)2-vitamin D3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt/PKB and mTOR mediated pathways in murine C2C12 skeletal myotubes.
Salles J; Chanet A; Giraudet C; Patrac V; Pierre P; Jourdan M; Luiking YC; Verlaan S; Migné C; Boirie Y; Walrand S
Mol Nutr Food Res; 2013 Dec; 57(12):2137-46. PubMed ID: 23929734
[TBL] [Abstract][Full Text] [Related]
20. 1,25(OH)2D3 Protects Trophoblasts Against Insulin Resistance and Inflammation Via Suppressing mTOR Signaling.
Li G; Lin L; Wang YL; Yang H
Reprod Sci; 2019 Feb; 26(2):223-232. PubMed ID: 29575997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
